Perioperative medicine & outcomes

Effect of Pericapsular Nerve Group Block on Prehabilitation in Femoral Neck Fractures: A Randomized, Double-Blind, Placebo-Controlled Trial

Anesth AnalgPublished Randomised controlled trial

Authors' conclusion

PENG block administered before the initial prehabilitation was associated with reduced movement-related pain and rescue analgesic use but did not improve the initial prehabilitation completion or postoperative functional recovery.

Study context

Population
Adults with Garden III to IV femoral neck fractures awaiting hip arthroplastyrandomised
Participants
100 adults
Comparison
Pericapsular nerve group (PENG) block vs saline before initial prehabilitation
  • PENGn = 50
  • Placebon = 50reference
Primary endpoint
Completion of all five predefined mobilization steps of the prehabilitation session
Methodological detailssingle-centre, double-blind, placebo-controlled
  • Single-centre
  • Double-blind
  • Placebo-controlled

Primary result

As reported in the abstract

Completion of all five predefined mobilization steps (full prehabilitation session)
  • PENG vs Placebo: P = 0.841
  • Intention-to-treat

Secondary outcomes

Rescue analgesia · within 24 hours

P = 0.028

Median

OutcomePENGPlaceboP value
Maximum movement pain during prehabilitation7 (IQR 5–8.75)8 (IQR 7–10)P = 0.022

Postoperative outcomes (Cumulated Ambulation Score POD 1-3, Barthel Index, LOS, discharge disposition)

No between-group differences in postoperative outcomes

Safety

No block-related or prehabilitation-related adverse events occurred

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Effect of Pericapsular Nerve Group Block on Prehabilitation in Femoral Neck Fractures: A Randomized, Double-Blind, Placebo-Controlled Trial. Anesth Analg. Published 15 June 2026. doi:10.1213/ane.0000000000008147

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.